TEACHERS ADVISORS, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 375 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$11,982,000
-18.3%
100,525
-25.2%
0.02%
-28.6%
Q4 2018$14,673,000
-65.8%
134,450
-49.4%
0.02%
-19.2%
Q3 2018$42,934,000
+246.0%
265,832
+183.2%
0.03%
+62.5%
Q2 2018$12,409,000
-14.8%
93,880
-52.3%
0.02%
-15.8%
Q1 2018$14,568,000
-3.2%
196,622
-27.3%
0.02%0.0%
Q4 2017$15,057,000
+28.1%
270,621
+4.5%
0.02%
+18.8%
Q3 2017$11,752,000
+41.1%
259,082
+4.9%
0.02%
+33.3%
Q2 2017$8,326,000
-3.3%
246,977
-15.1%
0.01%
-7.7%
Q1 2017$8,613,000
+40.9%
290,993
+30.6%
0.01%
+30.0%
Q4 2016$6,111,000
+29.6%
222,786
+190.1%
0.01%
+25.0%
Q3 2016$4,715,000
+104.7%
76,784
-36.4%
0.01%
+100.0%
Q2 2016$2,303,000
+1.8%
120,752
+4.2%
0.00%0.0%
Q1 2016$2,262,000
-49.3%
115,905
+0.1%
0.00%
-50.0%
Q4 2015$4,465,000
+27.2%
115,732
+5.9%
0.01%
+14.3%
Q3 2015$3,510,000
+5.7%
109,319
+0.2%
0.01%
+16.7%
Q2 2015$3,321,000
+121.7%
109,143
-3.3%
0.01%
+100.0%
Q1 2015$1,498,000
-1.5%
112,814
+7.4%
0.00%0.0%
Q4 2014$1,521,000
-31.4%
105,0800.0%0.00%
-25.0%
Q3 2014$2,217,000
-21.4%
105,080
+10.9%
0.00%
-33.3%
Q2 2014$2,822,000
+23.7%
94,739
-0.2%
0.01%
+20.0%
Q1 2014$2,281,000
+105.3%
94,912
+74.0%
0.01%
+66.7%
Q4 2013$1,111,000
-48.7%
54,559
+19.1%
0.00%
-40.0%
Q3 2013$2,164,000
+35.4%
45,819
+9.1%
0.01%
+25.0%
Q2 2013$1,598,00041,9880.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders